4//SEC Filing
Edick Paul R 4
Accession 0001867096-22-000007
CIK 0001867096other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:16 PM ET
Size
9.0 KB
Accession
0001867096-22-000007
Insider Transaction Report
Form 4
Edick Paul R
DirectorSee Remarks
Transactions
- Award
Common Stock
2022-01-03+600,000→ 1,408,064 total
Holdings
- 33,430(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001531178
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:16 PM ET
- Size
- 9.0 KB